Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Company Profile for Techulon Inc

Abstract:
Techulon is a life sciences company with a core capability in the development, characterization and synthesis of novel gene delivery techniques for cell-based therapeutics. Our proprietary nanoparticle delivery platform, Glycofect, is a polymer-based reagent that delivers DNA and RNA into cells with lower cell toxicity and high protein expression. The company is focused on delivery for therapeutically relevant cells such as primary cells. Applications for this new technology range from research on cellular metabolism to advanced forms of cancer treatment. First indications include neurodegenerative diseases and glioma.

Company Profile for Techulon Inc

Blacksburg, VA | Posted on September 24th, 2011

Company: Techulon Inc

Headquarters Address: 2200 Kraft Drive, Ste 2475
Blacksburg, VA 24060
Main Telephone: 540-443-9254

Website: www.techulon.com

Type of Organization: Private

Industry: Biotechnology

Key Executives: CEO: Frank Akers

####

For more information, please click here

Contacts:
Investor Relations
Contact:
Brett Malone

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project